氟-18α-甲基酪氨酸PET在胶质瘤患者中的临床价值:与氟-18氟脱氧葡萄糖PET的比较
研究纳入38例连续胶质瘤患者,比较18F-FAMT PET与18F-FDG PET的肿瘤/正常脑比值(T/N)与组织学特征的关系。18F-FAMT PET的T/N比值在高级别与低级别胶质瘤间差异有统计学意义(p=0.006),鉴别二者最佳截断值3.37,灵敏度81%、特异度67%、准确率76%、AUC 0.776,阳性预测值84%、阴性预测值62%。18F-FAMT PET在所有级别胶质瘤中T/N比值均显著高于18F-FDG PET,作者认为其是术前显示胶质瘤的有用放射性示踪剂。
要点
- 18F-FAMT PET的T/N比值在高、低级别胶质瘤间差异有统计学意义(p=0.006)。
- 18F-FAMT PET鉴别高、低级别胶质瘤最佳截断值3.37,灵敏度81%、特异度67%、准确率76%。
- 18F-FAMT PET在所有级别胶质瘤中T/N比值均显著高于18F-FDG PET。
核心结论
- 18F-FAMT摄取的T/N比值对检测高级别胶质瘤具有高阳性预测值。
- 18F-FAMT PET在低级别和高级别胶质瘤中均较18F-FDG PET具有更高的T/N比值和更好的肿瘤-正常脑对比。
- 作者认为18F-FAMT是术前显示胶质瘤的有用放射性示踪剂。
研究设计与样本
- 研究纳入38例连续胶质瘤患者,采用18F-FAMT PET与18F-FDG PET比较,计算肿瘤/正常脑比值(T/N比值),评估T/N比值与世界卫生组织肿瘤分级及MIB-1标记指数的关系,并用受试者工作特征(ROC)曲线分析评估T/N比值鉴别高级别与低级别胶质瘤的诊断价值。
主要发现
- 18F-FAMT PET的T/N比值中位数在II级、III级、IV级胶质瘤分别为2.85、4.65、4.09,高级别与低级别胶质瘤间差异有统计学意义(p=0.006)。
- 18F-FDG PET的T/N比值(p=0.016)和最大标准化摄取值(p=0.033)在高级别与低级别胶质瘤间均显示显著差异。
- 18F-FAMT PET的T/N比值在所有胶质瘤中与MIB-1标记指数无相关性,而18F-FDG PET的T/N比值呈正相关(r s=0.400,p=0.013)。
- 18F-FDG与18F-FAMT的T/N比值间观察到显著正相关(r s=0.454,p=0.004),但18F-FAMT PET的T/N比值中位数在所有级别胶质瘤中均显著高于18F-FDG PET。
关键数值与推荐
- 18F-FAMT PET鉴别高级别与低级别胶质瘤的ROC分析最佳截断值为3.37(灵敏度81%,特异度67%,准确率76%,ROC曲线下面积0.776)。
- 18F-FAMT PET的阳性预测值为84%,阴性预测值为62%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We investigated the relationship between metabolic activity and histological features of gliomas using fluorine-18α-methyltyrosine (18F-FAMT) positron emission tomography (PET) compared with fluorine-18 fluorodeoxyglucose (18F-FDG) PET in 38 consecutive glioma patients. The tumor to normal brain ratios (T/N ratios) were calculated, and the relationships between T/N ratio and World Health Organization tumor grade or MIB-1 labeling index were evaluated. The diagnostic values of T/N ratios were assessed using receiver operating characteristic (ROC) curve analyses to differentiate between high-grade gliomas (HGGs) and low-grade gliomas (LGGs). RESULTS: Median T/N ratio of 18F-FAMT PET was 2.85, 4.65, and 4.09 for grade II, III, and IV gliomas, respectively, with significant differences between HGGs and LGGs (p = 0.006). Both T/N ratio (p = 0.016) and maximum standardized uptake value (p = 0.033) of 18F-FDG PET showed significant differences between HGGs and LGGs. ROC analysis yielded an optimal cut-off of 3.37 for the T/N ratio of 18F-FAMT PET to differentiate between HGGs and LGGs (sensitivity 81%, specificity 67%, accuracy 76%, area under the ROC curve 0.776). Positive predictive value was 84%, and negative predictive value was 62%. T/N ratio of 18F-FAMT PET was not correlated with MIB-1 labeling index in all gliomas, whereas T/N ratio of 18F-FDG PET was positively correlated (r s = 0.400, p = 0.013). Significant positive correlation was observed between T/N ratios of 18F-FDG and 18F-FAMT (r s = 0.454, p = 0.004), but median T/N ratio of 18F-FAMT PET was significantly higher than that of 18F-FDG PET in all grades of glioma. CONCLUSIONS: The T/N ratio of 18F-FAMT uptake has high positive predictive value for detection of HGGs. 18F-FAMT PET had higher T/N ratio, with better tumor-normal brain contrast, compared to 18F-FDG PET in both LGGs and HGGs. Therefore, 18F-FAMT is a useful radiotracer for the preoperative visualization of gliomas.
引用
- Horiguchi K, Tosaka M, Higuchi T, et al. Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET. EJNMMI Res. 2017. PMID: 28567708. doi:10.1186/s13550-017-0298-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。